Stage II Pancreatic Cancer AJCC v8

general

Stage IIA includes: T3, N0, M0. T3: Tumor measuring more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)

Centers

Active Trials

$1.3B

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Stage IIB Pancreatic Cancer	9	—

Top Centers for Stage II Pancreatic Cancer AJCC v8(45)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center	High-Volume Research Center	4	—	73.2
2	OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive High-Volume Research Center	High-Volume Research Center	3	—	71.5
3	UF Health Cancer InstituteGainesville, FL NCI Clinical High-Volume Research Center	High-Volume Research Center	3	—	71.5
4	University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
5	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
6	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
7	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
8	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
9	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
10	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
11	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	2	—	63.3
12	UCI Chao Family Comprehensive Cancer CenterOrange, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
13	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
14	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program	Active Research Program	2	—	63.3
15	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	63.3
16	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	2	—	63.3
17	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
18	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
19	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
20	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
21	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
22	UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
23	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
24	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
25	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
26	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
27	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
28	Montefiore Einstein Comprehensive Cancer CenterBronx, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
29	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
30	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
31	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
32	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	1	—	42.4
33	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	1	—	42.4
34	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program	Active Research Program	1	—	42.4
35	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	1	—	42.4
36	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program	Active Research Program	1	—	42.4
37	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	1	—	42.4
38	Penn State Cancer InstituteHershey, PA Active Research Program	Active Research Program	1	—	42.4
39	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	42.4
40	Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program	Active Research Program	1	—	42.4
41	The University of Vermont Cancer CenterBurlington, VT Active Research Program	Active Research Program	1	—	42.4
42	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive		—	$754M	—
43	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive		—	$262M	—
44	Cleveland Clinic Cancer CenterCleveland, OH		—	$150M	—
45	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive		—	$103M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →